Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 1:13:100300.
doi: 10.1016/j.lanepe.2021.100300. eCollection 2022 Feb.

Gender effect in the ITALUNG screening trial. A comparison with UKLS and other trials

Affiliations

Gender effect in the ITALUNG screening trial. A comparison with UKLS and other trials

Donella Puliti et al. Lancet Reg Health Eur. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All the Authors of the manuscript declare not to have any conflict of interest.

References

    1. Field JK, Vulkan D, Davies MPA, et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. Lancet Regional Health – Europe. 2021;10 - PMC - PubMed
    1. Mascalchi M, Lopes Pegna A, Carrozzi L, et al. Does UKLS strategy increase the yield of screen-detected lung cancers? A comparison with ITALUNG. Thorax. 2016;71(10):950–951. - PubMed
    1. Paci E, Puliti D, Lopes Pegna A, et al. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017;72(9):825–831. - PubMed
    1. Puliti D, Mascalchi M, Carozzi FM, et al. Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors. Lung Cancer. 2019;138:72–78. - PubMed
    1. Ten Haaf K, van Rosmalen J, de Koning HJ. Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. Cancer Epidemiol Biomarkers Prev. 2015;24(1):154–161. - PMC - PubMed

LinkOut - more resources